Lifecare ASA

LIFE Ex. Subscription Rights today

Issuer: Lifecare ASA

Ex. date: 21 May 2024

Type of corporate action: Preferential rights issue

Other information: The shares in Lifecare ASA will from today, 21 May 2024, be

traded exclusive of the right to receive subscription rights for shares in the

preferential rights issue announced on 25 April 2024.

This information is published in accordance with the requirements of the

Continuing Obligations for Euronext Growth Oslo.

About us

Lifecare ASA is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market. Lifecare enables osmotic pressure as sensing principle, combined

with the ability to manipulate Nano-granular Tunnelling Resistive sensors

("NTR") on the sensor body for read-out of pressure variations. Lifecare's

sensor technology is referred to as "Sencell" and is suitable for identifying

and monitoring the occurrence of a wide range of analytes and molecules in the

human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, Lifecare ASA, [email protected], +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs,

This information is subject to disclosure under the Norwegian Securities

Trading Act, §5-12. The information was submitted for publication at

2024-05-21 08:00 CEST.

AI Terminal